ArticleFrontiers in psychiatry2026
FaReWell Depression - a randomized controlled trial of a physiotherapeutic program for the facial rehabilitation of wellbeing in depression.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Facial feedback mechanisms can modulate affective states. A series of clinical trials have shown that injection of botulinum toxin A can improve the symptoms of depression, probably via the disruption of proprioceptive afferences from the glabellar region to the brain. In extension of this research, we developed a physiotherapeutic program for the facial rehabilitation of wellbeing in depression (FaReWell Depression) with the objective to relax key facial muscles involved in the expression and experience of negative emotions and to tone and strengthen key facial muscles for the expression and experience of positive emotions. The program comprises a massage module with a focus on the glabellar (corrugator supercilii and procerus muscles) and perioral (mentalis and depressor anguli oris muscles) regions and a strength-training module with a focus on the cheek region (zygomaticus and orbicularis oculi muscles). We tested the therapeutic potential of this program in a randomized controlled trial. Methods: We assigned 49 patients with mild to moderate depression to either do a daily 15 minutes training session with the FaReWell Depression program or a rest exercise for the same duration as a control condition. The primary endpoint of the study was the change on the Montgomery-Åsberg Depression Rating Scale (MADRS) from the baseline to the point in time six weeks later. Results: The repeated measures analysis of covariance (ANCOVA) of the MADRS scores showed a significant group × time interaction effect ( Discussion: These findings provide preliminary evidence that a self-applied facial physiotherapeutic intervention can improve the symptoms of depression and warrants further investigation into this novel treatment approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.